NCT01407094View on ClinicalTrials.gov

Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

July 29, 2011

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Depression
Interventions
DRUG

Sertraline

50-200mg/day

DRUG

Placebo

1-4 pills per day

DRUG

BupropionXL

150-450 mg/day

Trial Locations (4)

10032

Columbia Univerisity New York City, New York

48104

University of Michigan Ann Arbor, Ann Arbor

75309

UT Southwestern Medical Center Dallas, Dallas

02114

Massachusetts General Hospital Boston, Boston

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT01407094 - Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression | Biotech Hunter | Biotech Hunter